| Target Price | $495.72 |
| Price | $436.87 |
| Potential | 13.47% |
| Number of Estimates | 34 |
| 34 Analysts have issued a price target Intuitive Surgical 2027 . The average Intuitive Surgical target price is $495.72. This is 13.47% higher than the current stock price. The highest price target is $719.25 64.64% , the lowest is $327.24 25.09% . | |
| A rating was issued by 40 analysts: 29 Analysts recommend Intuitive Surgical to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Intuitive Surgical stock has an average upside potential 2027 of 13.47% . Most analysts recommend the Intuitive Surgical stock at Purchase. |
36 Analysts have issued a sales forecast Intuitive Surgical 2026 . The average Intuitive Surgical sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
27 Analysts have issued an Intuitive Surgical EBITDA forecast 2026. The average Intuitive Surgical EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
37 Intuitive Surgical Analysts have issued a net profit forecast 2026. The average Intuitive Surgical net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
37 Analysts have issued a Intuitive Surgical forecast for earnings per share. The average Intuitive Surgical EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Intuitive Surgical...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Outperform
➜
Outperform
|
Unchanged | Oct 21 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 21 2026 |
| Evercore ISI Group |
In-Line
➜
In-Line
|
Unchanged | Oct 21 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Oct 21 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 21 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 21 2026 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Leerink Partners:
Outperform
➜
Outperform
|
Oct 21 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 21 2026 |
|
Unchanged
Evercore ISI Group:
In-Line
➜
In-Line
|
Oct 21 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Oct 21 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 21 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 21 2026 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 21 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


